Urapidil

Chemical formula: C₂₀H₂₉N₅O₃  Molecular mass: 387.484 g/mol  PubChem compound: 5639

Therapeutic indications

Urapidil is indicated for:

Severe and very severe hypertensive disease

Population group: only adults (18 years old or older)

Severe and very severe forms of hypertensive disease, hypertension resistant to treatment.

Controlled lowering of blood pressure in hypertensive patients during and/or after surgery.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypertensive crisis

Population group: only adults (18 years old or older)

Hypertensive emergencies (e.g. a critical rise in blood pressure).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypertension

Population group: only adults (18 years old or older)

Hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Urapidil is contraindicated in the following cases:

Aortic isthmus stenosis, arteriovenous shunt

at least one of
Congenital stenosis of aortic arch
Arteriovenous shunt

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) : URAPIDIL Prolonged-release capsule, hard
Summary of Product Characteristics (SPC) : URAPIDIL Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈